Exmedica
 
   




Delen via:




2005

    Home > Nieuws > 2005

Pfizer gevraagd Bextra van de markt te halen

Nieuws van: FDA-MedWatch
After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra from the market.
www.fda.gov/medwatch/SAFETY/2005/safety05.htm - 7 Apr 2005



« Vorige

[FDA Panel: Keep COX-2 Drugs on Market]

Volgende »

[Minder hulpmiddelen via de apotheken]

Gevonden op deze pagina: